Profil
Alexander D.
Cross served as President & CEO of Zoecon Corp.
from 1979 to 1985.
He was also Chairman & CEO of CytoPharm, Inc. Additionally, he served as a Director at MDRNA, Inc. and Ligand Pharmaceuticals, Inc. and as an Independent Director at Atossa Therapeutics, Inc. He was a Principal at NDA Partners LLC from 2003 to 2018.
Dr. Cross received his undergraduate and doctorate degrees from The University of Nottingham.
Ehemalige bekannte Positionen von Alexander Cross
| Unternehmen | Position | Ende |
|---|---|---|
NDA Partners LLC
NDA Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides strategy consulting services | Corporate Officer/Principal | 11.06.2018 |
| ATOSSA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.12.2013 |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services Researches, develops, manufactures and commercializes nasally administered forms of pharmaceuticals | Direktor/Vorstandsmitglied | 20.05.2009 |
| LIGAND PHARMACEUTICALS INCORPORATED | Direktor/Vorstandsmitglied | 17.03.2007 |
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology Develops natural interferon products | Vorsitzender | 01.08.2006 |
Ausbildung von Alexander Cross
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services Researches, develops, manufactures and commercializes nasally administered forms of pharmaceuticals | Commercial Services |
Ligand Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NDA Partners LLC
NDA Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides strategy consulting services | Commercial Services |
Zoecon Corp. | |
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology Develops natural interferon products | Health Technology |
















